News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs

NewsTrendsResourcesEventsOutsourcing-Pharma.comOpens in new window

Home
News
Trends
Resources
Events
Outsourcing-Pharma.comOpens in new window

Archives for May 14, 2018

← 2018

Lilly to bolster immuno-oncology program with Armo BioSciences purchase

14-May-2018

By Brittany Farb Gruber

In a move aimed to bolster its immuno-oncology program, Eli Lilly and Company has acquired Armo BioSciences for $50 per share, or approximately $1.6bn.

Headlines

Alchemab and Lilly collaborate to discover and develop ALS therapies

MaaT Pharma’s microbiome therapy scores phase 3 win

Adcentrx launches Phase 1 study for its next-generation ADC targeting advanced solid tumors

Promotional features

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

Paid for and content provided by Scorpius BioManufacturing

Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials

Paid for and in partnership with Thermo Fisher Scientific - Biosciences

Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics

Paid for and content provided by Just – Evotec Biologics

BioPharma-Reporter

Advertise with us
Apply to reuse our contentOpens in new window
Press Releases - Guidelines
About us
Contact us
Why Register?

Resources

Report a technical problem
Whitelist our newsletters
Help Centre
RSS Feed
Podcast
Archives